You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chronic hepatitis C virus genotype 6

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with

Completed
Has Results
  • Hepatitis C Virus Infection
  • +3 more
  • ABT-493 coformulated with ABT-530
  • (no location specified)
Jul 9, 2021

Hepatitis C Virus Trial (ABT-493/ABT-530)

Completed
Has Results
  • Hepatitis C Virus
  • (no location specified)
Jul 9, 2021

Hepatitis C Virus Infection, Chronic Hepatitis C, Compensated Cirrhosis Trial (ABT-493/ABT-530)

Completed
Has Results
  • Hepatitis C Virus Infection
  • +2 more
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C, HCV, Hepatitis C Virus Trial (glecaprevir/pibrentasvir)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir)

Completed
Has Results
  • Hepatitis C Virus (HCV)
  • San Diego, California
  • +24 more
Jul 14, 2021

Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)

Completed
  • Chronic Hepatitis c Genotype 1
  • Moscow, Russian Federation
  • +4 more
Oct 27, 2022

Seroconversion of Hepatitis c Virus Among CKD on Regular

Not yet recruiting
  • Hepatitis C Virus
    • (no location specified)
    Oct 25, 2023

    Occult Hepatitis C Virus Infection in Patients Born Before 1969

    Not yet recruiting
    • Hepatitis C, Chronic
    • +2 more
    • Meridan Bioscience Point of Care test against HCV antibodies
    • (no location specified)
    Apr 2, 2023

    Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus Trial (ABT-493/ABT-530, Sofosbuvir, Daclatasvir)

    Completed
    Has Results
    • Chronic Hepatitis C
    • +2 more
    • (no location specified)
    Jul 9, 2021

    Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, sofosbuvir (SOF), ribavirin (RBV))

    Completed
    Has Results
    • Chronic Hepatitis C Virus
    • Hepatitis C Virus
    • (no location specified)
    Jul 14, 2021

    Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

    Completed
    • Hepatitis C
    • Bradford, United Kingdom
    • +3 more
    Jan 4, 2023

    Chronic Hepatitis C Virus (HCV) Infection Trial (ABT-493/ABT-530, Placebo for ABT-493/ABT-530)

    Completed
    Has Results
    • Chronic Hepatitis C Virus (HCV) Infection
    • (no location specified)
    Jul 14, 2021

    Hepatitis C, Chronic Trial in Carlsbad (ISIS 14803)

    Completed
    • Hepatitis C, Chronic
    • ISIS 14803
    • Carlsbad, California
      Isis Pharmaceuticals
    Dec 1, 2022

    Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)

    Not yet recruiting
    • Liver Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 9, 2023

    Determine Hepatitis C Virus Infection Prevalence Among Patients

    Completed
    • Chronic Hepatitis c
    • Vasculitis
      • Mexico City, Mexico
        Hospital General de Mexico
      Mar 15, 2022

      Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir)

      Completed
      Has Results
      • Chronic Hepatitis C Infection
      • Compensated Cirrhosis
      • (no location specified)
      Jul 8, 2021

      Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493/ABT-530)

      Completed
      Has Results
      • Chronic Hepatitis C
      • +2 more
      • (no location specified)
      Jul 9, 2021

      Chronic Hepatitis C Virus Infection Trial (OBV/PTV/r, Sofosbuvir, Ribavirin (RBV))

      Completed
      Has Results
      • Chronic Hepatitis C Virus Infection
      • (no location specified)
      Jul 8, 2021

      Glecaprevir/Pibrentasvir in Chronic Hepatitis C Genotypes 1 to 6

      Completed
      • Hepatitis C Virus (HCV)
        • Makhachkala, Dagestan, Respublika, Russian Federation
        • +7 more
        Jun 23, 2022

        Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

        Completed
        Has Results
        • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
        • Phoenix, Arizona
        • +47 more
        Jun 27, 2022

        Zepatier in Patients With Substance Use

        Active, not recruiting
        • Hepatitis C
        • +3 more
        • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
        • Chicago, Illinois
          University of Illinois at Chicago
        Jun 28, 2022

        Hepatitis C Trial in Seoul

        Completed
        • Hepatitis C
          • Seoul, Korea, Republic of
            Local Institution
          Jan 6, 2022

          Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C Trial in Bucuresti (Bemnifosbuvir, Ruzasvir)

          Recruiting
          • Chronic Hepatitis C Virus
          • +4 more
          • Bucuresti, BUC, Romania
            Atea Study Site
          Jun 15, 2023

          Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/pibrentasvir adult formulation, Glecaprevir/pibrentasvir pediatric

          Completed
          Has Results
          • Hepatitis C Virus (HCV)
          • Glecaprevir/pibrentasvir adult formulation
          • Glecaprevir/pibrentasvir pediatric formulation
          • San Francisco, California
          • +37 more
          Sep 19, 2022